Fitzsimons Innovation Community is an integrated urban campus where health and life sciences companies of all sizes work on their next big things. Our customized workspace, collaborative campus, and proximity to one of the top health systems and medical schools in the country make our community the perfect place to put down roots and get to work.
MOVE-IN READY LAB SPACE
GROWTH OPPORTUNITIES
It’s not just additional space—it’s fifty sprawling acres of additional space. And it’s primed for ultra-custom, made-to-order facility development.
Fitzsimons Innovation Community and University of Colorado Anschutz Medical Campus working together.
Relationships that help you thrive.
FEATURED:
One of the most exciting times of year for us here at Fitzsimons Innovation Community is when we launch our Annual Innovation Report, and this year is no different. For the fourth year in a row, we are proud to share this report featuring updates, insight, and data about all the things that make our Community special.
Fitzsimons Innovation Community is where innovators come to turn ideas into business.
A monthly feature of a Fitzsimons Innovation Community visionary.
Our year in innovation.
Find out what’s happening on campus and across the industry.
An urban mountain lifestyle for work and play.
Everything you need.
Right here.
It’s not just any companies that work on the Fitzsimons Innovation Community campus. Currently, our campus is home to more than 80 visionary organizations and 800 employees in pharmaceuticals, cell and gene therapy, medical devices, molecular biology, diagnostics, and more. These companies are collaborating, thriving, and making major discoveries and advancements in health and care. And they’re all doing it right here.
Fitzsimons Innovation Community member companies are thriving. 62% of companies added employees to their workforce.
Most Fitzsimons Innovation Community member companies are actively involved in fundraising to power their progress.
Fitzsimons Innovation Community member companies introduced more than 16 new innovations to the market in 2023.
Last year, Fitzsimons Innovation Community member companies attracted more than $116M in investments to support R&D, prepare for clinical trials, accelerate commercialization, and retain or recruit talent.
Fitzsimons Innovation Community member companies made news with major breakthrough discoveries last year. Areas included molecular biology, pharmaceuticals, medical device, research tools, cell and gene therapy, material science, and diagnostics.
Fitzsimons Innovation Community member companies forged strategic partnerships for business collaboration, legal services, and venture capital opportunities.
*Fitzsimons Innovation Community Member Growth Survey responses (January – December 2021)
Rapid, inexpensive, universal, on-site, pan-cancer monitoring of therapy effectiveness; ultimately an inexpensive, universal, pan-cancer screening test. Early identification of hyper-progressive disease or any inactive therapy and switching to an effective therapy can be lifesaving!
Aldinger Colorado has been providing high-quality balance calibration and pipette calibration services throughout Colorado since 1998. Based in the Denver area, Aldinger specializes in the calibration of pipettes and laboratory balances and scales. Locally owned and operated, Aldinger Colorado is your full-service calibration company, offering on-site calibration and repair for most equipment. As a small, local Colorado business, we pride ourselves in the quality of our work and attention to customers.
Allander Biotechnologies develops cell-penetrating biologics for unmet clinical needs.
Alpha Omega Alpha, founded in 1902, is the national medical honor society. Alpha Omega Alpha's mission is recognizing high educational achievement; honoring gifted teaching; encouraging the development of leaders in academia and the community; supporting the ideals of humanism, and promoting service to others. Election to Alpha Omega Alpha is an honor signifying a lasting commitment to professionalism, leadership, scholarship, research, and community service. A lifelong honor, membership in the society confers recognition for a physician’s dedication to the profession and art of healing.
Alta Biotech is a fast-growing global contract research organization specializing in molecular biology, biochemistry, and cell biology services. Alta Biotech's core areas of expertise include plasmid DNA purification, gDNA, and total RNA extraction, gene synthesis, and a wide portfolio of customized fundamental life sciences research support. Alta Biotech has developed a variety of in-house technology platforms to provide fast, high-quality, and cost-effective services to exceed customer expectations. Their goal is to serve as a trusted bioscience partner to their customers.
APEX Orthopedic Investments, LLC is an asset management group led by leading Foot & Ankle surgeons, aimed at harnessing intellectual property to establish, invest in, and oversee a variety of portfolio companies focused on novel solutions to unmet clinical needs.
Aurora Oncology focuses on targeted detection and targeted treatment of early-stage cancer. Aurora is developing a non-invasive diagnostic test to detect over-expressed EGFR from cancer cells in the urine to enable treating patients that will respond to EGFR-targeted therapy. Aurora is also developing an advanced theranostic approach that allows for unprecedented sensitivity in imaging early-stage disease. EGFR-specific nanoparticles will allow detection of EGFR expressing cancer cells against a dark background with the subsequent ability to thermally ablate cells that have bound the particles.
Avidity develops and sells molecular affinity tools for connecting molecules. Avidity's patented AviTag™ technology employs a highly targeted enzymatic conjugation of a single biotin on a unique 15 amino acid peptide tag using the biotin ligase (BirA) from E. coli. Oriented on streptavidin-coated surfaces, this creates an ideal presentation for molecular binding interactions. Though Avidity is a small company, the scientific benefits of its AviTag have garnered notice. Currently, AviTag technology is licensed by seven of the world’s top ten pharmaceutical companies and is used by researchers in 22 countries.
Fitzsimons Innovation Community
